These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18588969)

  • 1. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
    Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
    Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
    Vandenbroucke JP; von Elm E; Altman DG; Gøtzsche PC; Mulrow CD; Pocock SJ; Poole C; Schlesselman JJ; Egger M;
    Epidemiology; 2007 Nov; 18(6):805-35. PubMed ID: 18049195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
    von Elm E; Altman DG; Egger M; Pocock SJ; Gøtzsche PC; Vandenbroucke JP;
    Epidemiology; 2007 Nov; 18(6):800-4. PubMed ID: 18049194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of Teratology Information Services (TIS).
    Hancock RL; Koren G; Einarson A; Ungar WJ
    Reprod Toxicol; 2007 Feb; 23(2):125-32. PubMed ID: 17184969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of drug-induced congenital defects.
    De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services.
    Hancock RL; Ungar WJ; Einarson A; Goodstadt M; Koren G
    Reprod Toxicol; 2008 Apr; 25(3):381-7. PubMed ID: 18423962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services.
    Schaefer C
    Congenit Anom (Kyoto); 2011 Mar; 51(1):6-11. PubMed ID: 21158950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection bias in Teratology Information Service pregnancy outcome studies.
    Johnson KA; Weber PA; Jones KL; Chambers CD
    Teratology; 2001 Aug; 64(2):79-82. PubMed ID: 11460258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 4: observational studies.
    Manchikanti L; Singh V; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(1):73-108. PubMed ID: 19165298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal risks of maternal pharmacotherapy: identifying signals.
    Koren G
    Handb Exp Pharmacol; 2011; 205():285-94. PubMed ID: 21882117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
    von Elm E; Altman DG; Egger M; Pocock SJ; Gøtzsche PC; Vandenbroucke JP;
    Lancet; 2007 Oct; 370(9596):1453-7. PubMed ID: 18064739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal outcome after technetium scintigraphy in early pregnancy.
    Schaefer C; Meister R; Wentzeck R; Weber-Schoendorfer C
    Reprod Toxicol; 2009 Sep; 28(2):161-6. PubMed ID: 19442716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy exposure registries: academic opportunities and industry responsibility.
    Wyszynski DF
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):93-101. PubMed ID: 19107953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
    Weber-Schoendorfer C; Schaefer C
    Mult Scler; 2009 Sep; 15(9):1037-42. PubMed ID: 19692433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.
    Wacker E; Navarro A; Meister R; Padberg S; Weber-Schoendorfer C; Schaefer C
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):353-60. PubMed ID: 25644395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.